Screening libraries of low molecular weight (LMW) compounds are foundational in early-stage drug discovery. However, the parallel synthesis of milligram-scale large libraries - especially for covalent inhibitors - remains constrained by resource-intensive purification protocols, high solvent consumption, and limited scalability. Electrophilic fragments such as acrylamides are widely used to target nucleophilic cysteines in disease-relevant proteins, but practical workflows to synthesize diverse covalent libraries in sufficient quantities and quality are lacking. Here, we report a high-throughput, chromatography-free workflow to synthesize and analyze 1235 acrylamides using a modified Ugi four-component reaction (U-4CR) featuring ammonia and acrylic acid. This strategy exploits direct product precipitation to replace chromatographic purification steps with simple filtration, enabling synthesis at scale with common parallel lab instrumentation. Our protocol provides a sustainable and modular solution to library generation, especially suitable for covalent drug discovery. Using complementary analytical methods - 1H NMR, UPLC-MS-UV, and AEMS - we systematically evaluated compound purity, identity, and long-term stability. The large dataset was systematically processed using PeakSel® (live dashboard at https://peaksel.elsci.io/a/domling_group/post/8gY7CqUMVtb), providing complementary information on compound quality and long-term stability. This platform delivers the largest fully profiled covalent electrophile library to date and offers a generalizable framework for sustainable library production and high-content analytical workflows. It complements emerging analytics-only approaches by offering a complete synthesis-to-analysis pipeline accessible with standard laboratory instrumentation.

AMEDIS Bobkova 786 4 198 00 Praha Czech Republic

Elsci LLC Arabkir district Komitas ave 1st lane b 20 0051 Yerevan Armenia

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry and Czech Advanced Technology and Research Institute Palacký University in Olomouc Krížkovského 511 8 779 00 Olomouc Czech Republic

SCIEX 71 Four Valley Drive Concord Ontario Canada

SCIEX Echo® MS Center of Excellence Marlborough Massachusetts 01752 USA

Zobrazit více v PubMed

Schuhmacher A. Hinder M. Dodel A. Gassmann O. Hartl D. Investigating the Origins of Recent Pharmaceutical Innovation. Nat. Rev. Drug Discovery. 2023;22(10):781–782. doi: 10.1038/d41573-023-00102-z. PubMed DOI

Macarron R. Banks M. N. Bojanic D. Burns D. J. Cirovic D. A. Garyantes T. Green D. V. S. Hertzberg R. P. Janzen W. P. Paslay J. W. Schopfer U. Sittampalam G. S. Impact of High-Throughput Screening in Biomedical Research. Nat. Rev. Drug Discovery. 2011;10(3):188–195. doi: 10.1038/nrd3368. PubMed DOI

Hillebrand L. Liang X. J. Serafim R. A. M. Gehringer M. Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: An Update. J. Med. Chem. 2024;67(10):7668–7758. doi: 10.1021/acs.jmedchem.3c01825. PubMed DOI

Sutanto F. Konstantinidou M. Dömling A. Covalent Inhibitors: A Rational Approach to Drug Discovery. RSC Med. Chem. 2020;11(8):876–884. doi: 10.1039/D0MD00154F. PubMed DOI PMC

Boss C. Hazemann J. Kimmerlin T. von Korff M. Lüthi U. Peter O. Sander T. Siegrist R. The Screening Compound Collection: A Key Asset for Drug Discovery. Chimia. 2017;71(10):667–677. doi: 10.2533/chimia.2017.667. PubMed DOI

Schuffenhauer A. Schneider N. Hintermann S. Auld D. Blank J. Cotesta S. Engeloch C. Fechner N. Gaul C. Giovannoni J. et al., Evolution of Novartis’ Small Molecule Screening Deck Design. J. Med. Chem. 2020;63(23):14425–14447. doi: 10.1021/acs.jmedchem.0c01332. PubMed DOI

Follmann M. Briem H. Steinmeyer A. Hillisch A. Schmitt M. H. Haning H. Meier H. An Approach towards Enhancement of a Screening Library: The Next Generation Library Initiative (NGLI) at Bayer—Against All Odds? Drug Discovery Today. 2019;24(3):668–672. doi: 10.1016/j.drudis.2018.12.003. PubMed DOI

Wang Y. Shaabani S. Ahmadianmoghaddam M. Gao L. Xu R. Kurpiewska K. Kalinowska-Tluscik J. Olechno J. Ellson R. Kossenjans M. Helan V. Groves M. Dömling A. Acoustic Droplet Ejection Enabled Automated Reaction Scouting. ACS Cent. Sci. 2019;5(3):451–457. doi: 10.1021/acscentsci.8b00782. PubMed DOI PMC

Wang Z. Shaabani S. Gao X. Ng Y. L. D. Sapozhnikova V. Mertins P. Krönke J. Dömling A. Direct–to–biology, Automated, Nano–Scale Synthesis, and Phenotypic Screening–Enabled E3 Ligase Modulator Discovery. Nat. Commun. 2023;14(1):8437. doi: 10.1038/s41467-023-43614-3. PubMed DOI PMC

Jones P. S. Boucharens S. McElroy S. P. Morrison A. Honarnejad S. van Boeckel S. van den Hurk H. et al., IMI European Lead Factory—Democratizing Access to High–Throughput Screening. Nat. Rev. Drug Discovery. 2022;21(4):245–246. doi: 10.1038/d41573-021-00196-3. PubMed DOI

Sutanto F. Shaabani S. Neochoritis C. G. Zarganes-Tzitzikas T. Patil P. Ghonchepour E. Dömling A. Multicomponent Reaction–Derived Covalent Inhibitor Space. Sci. Adv. 2021;7(6):eabd9307. doi: 10.1126/sciadv.abd9307. PubMed DOI PMC

Dömling A. Wang W. Wang K. Chemistry and Biology of Multicomponent Reactions. Chem. Rev. 2012;112(6):3083–3135. doi: 10.1021/cr100233r. PubMed DOI PMC

Wen X. McLaren D. G. High-Throughput Hit Identification with Acoustic Ejection Mass Spectrometry. SLAS Technol. 2025;31(6):100245. doi: 10.1016/j.slast.2025.100245. PubMed DOI

Liu C. Acoustic Ejection Mass Spectrometry: The Potential for Personalized Medicine. Expert Rev. Proteomics. 2025;22(4):141–147. doi: 10.1080/14789450.2025.2491356. PubMed DOI

Quinn A. Ivosev G. Chin J. Mongillo R. Veiga C. Covey T. R. Kapinos B. Khunte B. Zhang H. Troutman M. D. Liu C. High-Throughput Compound Quality Assessment with High-Mass-Resolution Acoustic Ejection Mass Spectrometry: An Automatic Data Processing Toolkit. Anal. Chem. 2024;96(21):8381–8389. doi: 10.1021/acs.analchem.3c05435. PubMed DOI

Dömling Group, Plated DMSO Stock Solutions of Acrylamides, 2024

Lucas S. C. C. Milbradt A. G. Blackwell J. H. Bonomo S. Brierley A. Cassar D. J. Freeman J. Hadfield T. E. Morrill L. A. Riemens R. Sarda S. et al., Design of a Lead–Like Cysteine–Targeting Covalent Library and the Identification of Hits to Cys55 of Bfl–1. J. Med. Chem. 2024;67(13):11209–11225. doi: 10.1021/acs.jmedchem.4c00781. PubMed DOI